Details for: TCEAL4
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 49.86rCSI 49.04%PRS 38.32
-
CSI 45.29rCSI 56.03%PRS 32.49
-
CSI 44.97rCSI 43.29%PRS 36.88
-
CSI 39.66rCSI 54.04%PRS 31.1
-
CSI 35.5rCSI 29.76%PRS 41.2
-
CSI 35.34rCSI 31.08%PRS 27.06
-
CSI 27.74rCSI 76.23%PRS 52.06
-
CSI 26.57rCSI 27.84%PRS 38.24
-
CSI 25.25rCSI 55.91%PRS 33.56
-
CSI 23.9rCSI 36.44%PRS 33.52
-
CSI 22.55rCSI 65.27%PRS 38.94
-
CSI 21.65rCSI 29.6%PRS 46.99
-
CSI 20.7rCSI 40.26%PRS 37.7
-
CSI 18.46rCSI 27.43%PRS 39.44
-
CSI 18.28rCSI 14.86%PRS 37.04
-
CSI 18.1rCSI 25.83%PRS 38.81
-
CSI 17.02rCSI 22.3%PRS 48.69
-
CSI 16.67rCSI 18.26%PRS 39.88
-
CSI 15.83rCSI 10.52%PRS 40.39
-
CSI 15.57rCSI 61.99%PRS 52.1
-
CSI 15.06rCSI 18.07%PRS 34.62
-
CSI 14.77rCSI 11.1%PRS 38.86
-
CSI 14.4rCSI 32.86%PRS 31.2
-
CSI 14.34rCSI 19.86%PRS 42.61
-
CSI 13.98rCSI 36.81%PRS 59.51
-
CSI 13.51rCSI 24.55%PRS 51.89
-
CSI 13.32rCSI 11.03%PRS 36.91
-
CSI 13.19rCSI 37.11%PRS 38.76
-
CSI 12.92rCSI 30.8%PRS 56.78
-
CSI 12.71rCSI 59.26%PRS 60.71
-
CSI 12.66rCSI 21.89%PRS 28.39
-
CSI 12.19rCSI 26.84%PRS 40.09
-
CSI 12.01rCSI 19.07%PRS 45.5
-
CSI 11.8rCSI 9.33%PRS 25.79
-
CSI 11.78rCSI 10.96%PRS 35.96
-
CSI 11.22rCSI 36.01%PRS 44.59
-
CSI 11.02rCSI 21.88%PRS 36.25
-
CSI 10.74rCSI 16.5%PRS 40.82
-
CSI 10.51rCSI 10.98%PRS 68.7
-
CSI 10.36rCSI 9.2%PRS 35.67
-
CSI 10.04rCSI 44.6%PRS 34.82
-
CSI 9.91rCSI 10.36%PRS 36.33
-
CSI 9.69rCSI 20.1%PRS 35.06
-
CSI 9.64rCSI 26.57%PRS 33.94
-
CSI 9.63rCSI 10.05%PRS 36.76
-
CSI 9.53rCSI 7.06%PRS 31.1
-
CSI 9.5rCSI 74.44%PRS 54.83
-
CSI 9.21rCSI 13.2%PRS 44.2
-
CSI 9.17rCSI 12.53%PRS 40.31
-
CSI 9.16rCSI 49.87%PRS 60.81
-
CSI 9.16rCSI 11.4%PRS 21.9
-
CSI 9.1rCSI 26.36%PRS 29.19
-
CSI 8.9rCSI 26.26%PRS 40.52
-
CSI 8.66rCSI 10.46%PRS 42.81
-
CSI 8.64rCSI 45.44%PRS 46.48
-
CSI 8.64rCSI 20.64%PRS 47.6
-
CSI 8.63rCSI 50.22%PRS 47.55
-
CSI 8.62rCSI 50.7%PRS 67.89
-
CSI 8.46rCSI 9.07%PRS 33.97
-
CSI 8.33rCSI 88.24%PRS 39.48
-
CSI 8.25rCSI 10.05%PRS 43.2
-
CSI 8.23rCSI 7.1%PRS 45.93
-
CSI 8.21rCSI 12.97%PRS 36.87
-
CSI 8.17rCSI 35.44%PRS 52.66
-
CSI 8.06rCSI 13.06%PRS 35.32
-
CSI 8.05rCSI 18.9%PRS 46.21
-
CSI 7.73rCSI 10.57%PRS 39
-
CSI 7.72rCSI 28.91%PRS 30.84
-
CSI 7.6rCSI 10.1%PRS 40.03
-
CSI 7.6rCSI 11.6%PRS 36.5
-
CSI 7.51rCSI 6.22%PRS 34.62
-
CSI 7.48rCSI 18.93%PRS 43.66
-
CSI 7.48rCSI 57.31%PRS 59.07
-
CSI 7.42rCSI 9.52%PRS 34.48
-
CSI 7.35rCSI 11.36%PRS 34.31
-
CSI 7.33rCSI 8.48%PRS 27.74
-
CSI 7.29rCSI 16.1%PRS 26.64
-
CSI 7.17rCSI 9.12%PRS 40.82
-
CSI 7.11rCSI 10.41%PRS 73.8
-
CSI 7.09rCSI 20.14%PRS 37.04
-
CSI 6.98rCSI 13.31%PRS 52.64
-
CSI 6.95rCSI 14.11%PRS 21.86
-
CSI 6.95rCSI 6.38%PRS 42.52
-
CSI 6.83rCSI 9.49%PRS 36.15
-
CSI 6.83rCSI 55.51%PRS 32.45
-
CSI 6.82rCSI 23.93%PRS 52.38
-
CSI 6.81rCSI 11.22%PRS 41.12
-
CSI 6.78rCSI 12.32%PRS 31.44
-
CSI 6.71rCSI 14.49%PRS 71.48
-
CSI 6.65rCSI 12.69%PRS 59.89
-
CSI 6.61rCSI 10.25%PRS 46.72
-
CSI 6.51rCSI 13.38%PRS 32.96
-
CSI 6.42rCSI 15.44%PRS 47
-
CSI 6.27rCSI 32.36%PRS 59.87
-
CSI 6.24rCSI 41.07%PRS 76.1
-
CSI 6.24rCSI 4.91%PRS 41.9
-
CSI 6.22rCSI 15.12%PRS 22.52
-
CSI 6.16rCSI 5.57%PRS 33.24
-
CSI 6.11rCSI 5.89%PRS 28.08
-
CSI 6.03rCSI 10.63%PRS 35.16
-
CSI 0.2rCSI 4.6%PRS 90.3%
-
CSI 0.2rCSI 5.7%PRS 76.2%
-
CSI 0.3rCSI 7.0%PRS 65.7%
-
CSI 0.4rCSI 0.8%PRS 56.6%
-
CSI 0.4rCSI 1.2%PRS 24.2%
-
CSI 0.5rCSI 7.7%PRS 77.9%
-
CSI 0.5rCSI 2.7%PRS 51.3%
-
CSI 0.5rCSI 7.4%PRS 71.4%
-
CSI 0.5rCSI 5.8%PRS 57.3%
-
CSI 0.6rCSI 7.5%PRS 65.3%
-
CSI 0.6rCSI 4.7%PRS 72.1%
-
CSI 0.6rCSI 2.7%PRS 59.6%
-
CSI 0.6rCSI 1.6%PRS 30.8%
-
CSI 0.6rCSI 4.3%PRS 63.9%
-
CSI 0.7rCSI 6.0%PRS 58.9%
-
CSI 0.7rCSI 16.0%PRS 66.8%
-
CSI 0.7rCSI 14.6%PRS 84.5%
-
CSI 0.7rCSI 7.1%PRS 65.1%
-
CSI 0.8rCSI 5.3%PRS 56.3%
-
CSI 0.8rCSI 7.3%PRS 79.9%
-
CSI 0.8rCSI 2.1%PRS 68.4%
-
CSI 0.9rCSI 1.6%PRS 22.4%
-
CSI 0.9rCSI 5.2%PRS 70.6%
-
CSI 0.9rCSI 1.7%PRS 57.1%
-
CSI 0.9rCSI 1.7%PRS 23.9%
-
CSI 1.0rCSI 4.7%PRS 39.0%
-
CSI 1.0rCSI 23.1%PRS 59.2%
-
CSI 1.0rCSI 2.5%PRS 28.5%
-
CSI 1.1rCSI 2.3%PRS 58.0%
-
CSI 1.1rCSI 3.2%PRS 60.5%
-
CSI 1.1rCSI 1.7%PRS 52.5%
-
CSI 1.1rCSI 3.2%PRS 54.6%
-
CSI 1.1rCSI 2.1%PRS 45.2%
-
CSI 1.1rCSI 5.0%PRS 53.5%
-
CSI 1.2rCSI 1.7%PRS 33.3%
-
CSI 1.2rCSI 4.4%PRS 56.3%
-
CSI 1.2rCSI 2.8%PRS 48.7%
-
CSI 1.2rCSI 4.4%PRS 24.0%
-
CSI 1.2rCSI 3.1%PRS 36.4%
-
CSI 1.2rCSI 1.9%PRS 30.7%
-
CSI 1.2rCSI 5.7%PRS 64.3%
-
CSI 1.2rCSI 2.8%PRS 35.5%
-
CSI 1.3rCSI 5.3%PRS 61.8%
-
CSI 1.3rCSI 8.0%PRS 73.2%
-
CSI 1.3rCSI 4.5%PRS 73.1%
-
CSI 1.4rCSI 2.2%PRS 46.5%
-
CSI 1.4rCSI 2.0%PRS 37.4%
-
CSI 1.4rCSI 33.1%PRS 23.4%
-
CSI 1.4rCSI 2.2%PRS 53.7%
-
CSI 1.5rCSI 25.7%PRS 74.8%
-
CSI 1.5rCSI 4.6%PRS 48.4%
-
CSI 1.6rCSI 2.6%PRS 23.2%
-
CSI 1.6rCSI 2.2%PRS 58.6%
-
CSI 1.7rCSI 3.4%PRS 58.9%
-
CSI 1.7rCSI 2.6%PRS 40.5%
-
CSI 1.7rCSI 9.7%PRS 58.4%
-
CSI 1.7rCSI 2.8%PRS 28.4%
-
CSI 1.7rCSI 4.1%PRS 63.7%
-
CSI 1.8rCSI 2.5%PRS 50.0%
-
CSI 1.8rCSI 4.6%PRS 40.4%
-
CSI 1.8rCSI 2.7%PRS 52.7%
-
CSI 1.8rCSI 7.2%PRS 58.7%
-
CSI 1.8rCSI 6.1%PRS 47.4%
-
CSI 1.8rCSI 3.9%PRS 51.2%
-
CSI 1.9rCSI 4.7%PRS 52.7%
-
CSI 2.0rCSI 2.1%PRS 52.1%
-
CSI 2.0rCSI 10.0%PRS 81.2%
-
CSI 2.0rCSI 45.5%PRS 75.4%
-
CSI 2.1rCSI 1.8%PRS 39.7%
-
CSI 2.1rCSI 11.9%PRS 47.2%
-
CSI 2.1rCSI 9.2%PRS 31.2%
-
CSI 2.2rCSI 4.3%PRS 64.2%
-
CSI 2.2rCSI 1.5%PRS 37.9%
-
CSI 2.3rCSI 11.1%PRS 46.7%
-
CSI 2.3rCSI 3.2%PRS 33.9%
-
CSI 2.3rCSI 68.2%PRS 61.5%
-
CSI 2.3rCSI 13.5%PRS 24.4%
-
CSI 2.3rCSI 8.2%PRS 22.2%
-
CSI 2.3rCSI 5.0%PRS 43.0%
-
CSI 2.4rCSI 5.2%PRS 50.6%
-
CSI 2.4rCSI 4.2%PRS 30.6%
-
CSI 2.4rCSI 2.8%PRS 39.9%
-
CSI 2.4rCSI 3.5%PRS 38.6%
-
CSI 2.4rCSI 9.1%PRS 32.0%
-
CSI 2.4rCSI 2.9%PRS 23.1%
-
CSI 2.5rCSI 2.8%PRS 47.1%
-
CSI 2.5rCSI 6.4%PRS 42.3%
-
CSI 2.5rCSI 2.4%PRS 50.9%
-
CSI 2.6rCSI 1.9%PRS 54.2%
-
CSI 2.7rCSI 7.0%PRS 33.2%
-
CSI 2.7rCSI 40.3%PRS 60.4%
-
CSI 2.7rCSI 4.0%PRS 46.1%
-
CSI 2.8rCSI 3.6%PRS 24.0%
-
CSI 2.9rCSI 3.6%PRS 45.0%
-
CSI 2.9rCSI 4.5%PRS 44.6%
-
CSI 3.0rCSI 7.2%PRS 33.6%
-
CSI 3.0rCSI 9.5%PRS 33.2%
-
CSI 3.0rCSI 6.8%PRS 35.7%
-
CSI 3.0rCSI 2.4%PRS 51.3%
-
CSI 3.1rCSI 5.9%PRS 60.7%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3506570685
Symbol: TCAL4_HUMAN
Name: Transcription elongation factor A protein-like 4
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 12905813
Title: Cloning of human B lymphocyte activation-related novel gene.
PubMed ID: 12905813
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15772651
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22814378
Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
PubMed ID: 22814378
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
Sequence Information:
- Length: 215
- Mass: 24647
- Checksum: 53420116CD9A7A0B
- Sequence:
MEKLYSENEG MASNQGKMEN EEQPQDERKP EVTCTLEDKK LENEGKTENK GKTGDEEMLK DKGKPESEGE AKEGKSEREG ESEMEGGSER EGKPEIEGKP ESEGEPGSET RAAGKRPAED DVPRKAKRKT NKGLAHYLKE YKEAIHDMNF SNEDMIREFD NMAKVQDEKR KSKQKLGAFL WMQRNLQDPF YPRGPREFRG GCRAPRRDIE DIPYV